Keywords: بدخیمی هماتولوژیک; CVA; Database; Hematologic malignancy; Hospitalized patients; Outcomes;
مقالات ISI بدخیمی هماتولوژیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بدخیمی هماتولوژیک; VTE; venous thromboembolism; HSCT; hematopoietic stem cell transplant; LMWH; low molecular weight heparin; IMIDs; immunomodulatory drugs; AML; acute myeloid leukemia; IQR; interquartile range; TAT; thrombin antithrombin; FVII; factor VII; FVIII; factor VI
Keywords: بدخیمی هماتولوژیک; Hematologic malignancy; Centaurea albonitens; Vincristine; Apoptosis;
Keywords: بدخیمی هماتولوژیک; Immune tolerance; Vaccination; Dendritic cells; Hematologic malignancy; Checkpoint inhibitors; CAR-T; IMiDs;
Keywords: بدخیمی هماتولوژیک; Primary immunodeficiency; Hematologic malignancy; Lymphoma; Leukemia; Hodgkin; AD; Autosomal dominant; ADA; Adenosine deaminase; AML; Acute myeloid leukemia; AR; Autosomal recessive; CID; combined immunodeficiency; HL; Hodgkin lymphoma; HLH; Hemophagocyti
Keywords: بدخیمی هماتولوژیک; Chemotherapy; Geriatric; Hematologic malignancy; Survival; Treatment effect;
Keywords: بدخیمی هماتولوژیک; Kidney transplantation; multiple myeloma; autologous stem cell transplantation (ASCT); outcomes; end-stage renal disease (ESRD); kidney failure; renal replacement therapy (RRT); RRT modality; hematologic malignancy; light chain deposition disease (LCDD);
Keywords: بدخیمی هماتولوژیک; Hematopoietic cell transplantation (HCT); Survival; Infants; Pediatric; Late effects; Hematologic malignancy; Relapse; Total body irradiation; Graft-versus-host disease;
Keywords: بدخیمی هماتولوژیک; Pneumonia; Hematopoietic cell transplantation; Hematologic malignancy; Community respiratory virus infection; Cytomegalovirus;
Keywords: بدخیمی هماتولوژیک; Fungal pneumonia; Neutropenia; Hematologic malignancy; Stem cell transplant; Immunocompromised host pneumonia; Galactomannan;
Keywords: بدخیمی هماتولوژیک; Pulmonary complications; Lung infiltrates; Hematopoietic cell transplant; Hematologic malignancy; Diagnosis; Pneumonia; Bronchoscopy;
Keywords: بدخیمی هماتولوژیک; Bacterial pneumonia; Cancer; Neutropenia; Hematologic malignancy; Stem cell transplant; Immunocompromised host pneumonia;
Keywords: بدخیمی هماتولوژیک; Viral pneumonia; Hematologic malignancy; Stem cell transplant; Immunocompromised host pneumonia;
Keywords: بدخیمی هماتولوژیک; Antifungal prophylaxis; Invasive aspergillosis; Micafungin; Hematologic malignancy; Galactomannan;
Keywords: بدخیمی هماتولوژیک; Hematologic malignancy; gastrointestinal; symptom cluster; symptom distress; symptom interference; quality of life;
Keywords: بدخیمی هماتولوژیک; Computerized physician order entry; Chemotherapeutic drugs; Hematologic malignancy; Ordering time; Dose dispersion;
Keywords: بدخیمی هماتولوژیک; Hematologic malignancy; Intensive care; Critical care;
Keywords: بدخیمی هماتولوژیک; High-flow oxygen therapy; Acute respiratory failure; Hematologic malignancy
Keywords: بدخیمی هماتولوژیک; Coronavirus; Respiratory virus; Hematopoietic stem cell transplant; Hematologic malignancy;
Keywords: بدخیمی هماتولوژیک; Hematologic malignancy; Hypereosinophilia; Hypereosinophilic syndrome; Lymphoma; Leukemia; AICL; Angioimmunoblastic T-cell leukemia; AML; Acute myelogenous leukemia; ATLL; Adult T-cell lymphoma/leukemia; BE; Blood eosinophilia; CEL; Chronic eosinophilic l
Keywords: بدخیمی هماتولوژیک; Clinical trials; Dose-response relationship; Hematologic malignancy; Overall response rate; Post hoc analysis; Proteasome inhibitor
Keywords: بدخیمی هماتولوژیک; Human rhinovirus; Viral pneumonia; Rhinovirus species; Immunocompromised hosts; Hematologic malignancy;
Keywords: بدخیمی هماتولوژیک; Immunohistochemistry; Hematologic malignancy; Protein expression; Genetic alteration;
Keywords: بدخیمی هماتولوژیک; Alternative donor transplantation; Donor selection algorithm; Hematologic malignancy
Keywords: بدخیمی هماتولوژیک; Secondary pulmonary alveolar proteinosis; Hematologic malignancy; Bronchoalveolar lavage; Opportunistic infections; Hematopoietic stem cell transplantation
Keywords: بدخیمی هماتولوژیک; HCT; hematopoietic cell transplantation Acronyms; HCT; hematopoietic cell transplantation; WBC; white blood cell; SNS; sympathetic nervous system; HPA; hypothalamic-pituitary-adrenal; HSC; hematopoietic stem cells; CTXD; Cancer and Treatment Distress;
Keywords: بدخیمی هماتولوژیک; Breakthrough infections; Febrile neutropenia; Hematologic malignancy
Engagement with INSPIRE, an Online Program for Hematopoietic Cell Transplantation Survivors
Keywords: بدخیمی هماتولوژیک; Hematopoietic cell transplantation; Engagement; Online; Internet; Website; Cancer survivors; Hematologic malignancy; Blood and marrow transplantation;
Polypharmacy, potentially inappropriate medications and drug-drug interactions in geriatric patients with hematologic malignancy: Observational single-center study of 122 patients
Keywords: بدخیمی هماتولوژیک; Polypharmacy; Potentially inappropriate medications; Drug-drug interactions; Geriatric patients; Hematologic malignancy;
Which donor is better when a matched donor is not available domestically? Comparison of outcomes of allogeneic stem cell transplantation with haploidentical and international donors in a homogenous ethnic population
Keywords: بدخیمی هماتولوژیک; Stem cell transplantation; Haploidentical; Unrelated donors; Hematologic malignancy;
Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome
Keywords: بدخیمی هماتولوژیک; Hematologic malignancy; Pseudomonas; Bacteremia; Risk factors; Outcome;
Anti-tumor activity of PI3K-δ inhibitor in hematologic malignant cells: Shedding new light on resistance to Idelalisib
Keywords: بدخیمی هماتولوژیک; Hematologic malignancy; PI3K signaling pathway; Idelalisib; Arsenic trioxide; Apoptosis;
Efficacy of recombinant factor VIIa for severe bleeding complicated by platelet transfusion refractoriness in patients with hematologic malignancies
Keywords: بدخیمی هماتولوژیک; rFVIIa; recombinant factor VIIa; PTR; platelet transfusion refractoriness; CR; complete responses; PR; partial response; NR; no response; CCI; corrected count increment; PI; platelet count increment; BSA; body surface area; PD; the dose of platelets trans
Allogeneic hematopoietic stem cell transplantation following donor CIK cell infusion: A phase I study in patients with relapsed/refractory hematologic malignancies
Keywords: بدخیمی هماتولوژیک; ALL; acute lymphocytic leukemia; AML; acute myeloid leukemia; ATG; anti thymus globulin; CIK; cytokine-induced killer; CML; chronic myelogenous leukemia; CML-BP; chronic myeloid leukemia; DLI; Donor lymphocyte infusion; F-Bu-Cy; fludarabine busulfan and c
The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitors
Keywords: بدخیمی هماتولوژیک; Pim kinase; pan Pim kinase inhibitor; Hematologic malignancy; Multiple myeloma; KMS-12;
All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies
Keywords: بدخیمی هماتولوژیک; Metabolic syndrome; Hematologic malignancy; Obesity; Dyslipidemia; Lipid signaling; Reactive oxygen species; Adipokines; Inflammation; Insulin resistance; Insulin signaling; IGF-1; Metformin
Fusariose disséminée au cours d’une autogreffe de moelle osseuse
Keywords: بدخیمی هماتولوژیک; Fusariose; Hémopathie maligne; AntifongiqueFusariosis; Hematologic malignancy; Antifungal drugs
Relationship of Body Mass Index and Arm Anthropometry to Outcomes after Pediatric Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies
Keywords: بدخیمی هماتولوژیک; Hematopoietic cell transplantation; Hematologic malignancy; Body mass index; Arm anthropometry; Children
Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Is Underused as a Curative Therapy in Eligible Patients from the United States
Keywords: بدخیمی هماتولوژیک; Allogeneic hematopoietic cell transplantation; Utilization; National Marrow Donor Program; Unrelated donor; Hematologic malignancy
Histone Deacetylase Inhibitors in Multiple Myeloma: Rationale and Evidence for Their Use in Combination Therapy
Keywords: بدخیمی هماتولوژیک; Hematologic malignancy; Histone modification; Immunomodulatory agent; Proteasome inhibitor
Normal hematopoiesis and hematologic malignancies: Role of canonical Wnt signaling pathway and stromal microenvironment
Keywords: بدخیمی هماتولوژیک; Canonical Wnt signaling pathway; β-catenin; Hematopoiesis; Hematologic malignancy; Chemoresistance; Blood cancer
Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: What can be learned from hematologic malignancies?
Keywords: بدخیمی هماتولوژیک; Epigenetic processes; Hematologic malignancy; Risk factors; Anticancer treatment; Interindividual variability; Chemoresistance
Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit
Keywords: بدخیمی هماتولوژیک; Prognosis; Hematologic malignancy; Intensive care unit;
Clinical and histopathologic review of Schnitzler syndrome: The Mayo Clinic experience (1972-2011)
Keywords: بدخیمی هماتولوژیک; anakinra; hematologic malignancy; hypocomplementemia; lymphoproliferative disease; monoclonal gammopathy; neutrophilic urticarial dermatosis; Schnitzler syndrome; urticaria; Waldenström macroglobulinemiaIL, interleukin; LE, lupus erythematosus; NUD, neutr
Up-regulation of ABCB1/P-glycoprotein by escaping promoter hypermethylation indicates poor prognosis in hematologic malignancy patients with and without bone marrow transplantation
Keywords: بدخیمی هماتولوژیک; ATP binding cassette; Multidrug resistance; P-glycoprotein; Methylation; Hematologic malignancy
Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: Risk factors and impact on mortality
Keywords: بدخیمی هماتولوژیک; Acinetobacter baumannii; Risk factors; Outcome; Hematologic malignancy; Critically ill
Genomic alterations in myeloid neoplasms with novel, apparently balanced translocations
Keywords: بدخیمی هماتولوژیک; Cytogenetics; array CGH; chromosomal rearrangement; hematologic malignancy;
PET-Computed Tomography for Radiation Treatment Planning of Lymphoma and Hematologic Malignancies
Keywords: بدخیمی هماتولوژیک; FDG-PET; Radiation treatment; Lymphoma; Hematologic malignancy;
Relevance and Clinical Implications of Tumor Cell Mobilization in the Autologous Transplant Setting
Keywords: بدخیمی هماتولوژیک; Plerixafor; Tumor cell mobilization; Hematopoietic stem cell transplantation; Hematologic malignancy; Non-Hodgkin’s lymphoma; Multiple myeloma; Acute myeloid leukemia
The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease
Keywords: بدخیمی هماتولوژیک; Febrile neutropenia; Prognosis; Hematologic malignancy; Albumin; Bicarbonate; C-reactive protein;